Literature DB >> 2234501

Extracellular tumor necrosis factor induces a decreased K+ conductance in an identified neuron of Aplysia kurodai.

M Sawada1, N Hara, T Maeno.   

Abstract

Recombinant human tumor necrosis factor (rhTNF) was pressure-applied onto the the soma of identified neuron R12 in the Aplysia abdominal ganglion. rhTNF induced a slow inward current (ITNF, 80-100 s in duration, 5-10 nA in amplitude) associated with a conductance decrease. ITNF begins 1-2 s after applying rhTNF and peaks in 5-6 s. ITNF was decreased by hyperpolarization and had a reversal potential of approximately -87 mV (close to the K+ equilibrium potential). Ion substitution and pharmacological experiments suggest that ITNF is due to a decreased K+ conductance and that TNF, a product of macrophages, may form an important link in communications between nervous and immune systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2234501     DOI: 10.1016/0304-3940(90)90458-l

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation.

Authors:  Maria Schäfers; Doo H Lee; Dominik Brors; Tony L Yaksh; Linda S Sorkin
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

2.  Tumor Necrosis Factor-α Suppresses Activation of Sustained Potassium Currents in Rat Small Diameter Sensory Neurons.

Authors:  Bao-Gang Liu; Maxim Dobretsov; Joseph R Stimers; Jun-Ming Zhang
Journal:  Open Pain J       Date:  2008-01-01

Review 3.  Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.

Authors:  Ian A Clark; Bryce Vissel
Journal:  J Neuroinflammation       Date:  2016-09-05       Impact factor: 8.322

4.  P2 receptors and chronic pain.

Authors:  Kazuhide Inoue
Journal:  Purinergic Signal       Date:  2007-01-19       Impact factor: 3.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.